CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
Parameter Counting
，更多细节参见夫子
Что думаешь? Оцени!
Александра Синицына (Ночной линейный редактор)
API Reference: See the API.md for complete documentation